AAP
LFMD icon

Ardsley Advisory Partners’s LifeMD LFMD Stock Holding History

Ardsley Advisory Partners’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-250,000
Closed -$1.55M – 139
2021
Q3 		$1.55M Buy
+250,000
New +$2.13M 0.24% 58

Other funds holding LFMD

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIA
Barry Investment Advisors New Bedford, Massachusetts $478M AUM 23.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ardsley Advisory Partners's LFMD Position: Q4 2021 in Review

Ardsley Advisory Partners sold out of LifeMD (LFMD) in Q4 2021, closing a stake of 250,000 shares — an estimated $1.55M sold.

Ardsley Advisory Partners first reported a position in LFMD in Q3 2021 and held it in 1 quarter. The position peaked at $1.55M in Q3 2021. 53 funds tracked by Wall St. Rank hold LFMD as of Q4 2021.

  • Ardsley Advisory Partners reported no remaining LifeMD position as of Q4 2021 after selling out during the quarter.
  • Ardsley Advisory Partners sold 250,000 LifeMD shares in Q4 2021, an estimated $1.55M.
  • Ardsley Advisory Partners first reported a position in LifeMD in Q3 2021 and held it in 1 quarter.
  • Ardsley Advisory Partners's LifeMD position peaked at $1.55M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held LifeMD as of Q4 2021.

Based on Ardsley Advisory Partners's 13F filing for Q4 2021, filed 14 Feb 2022.